Galectin Therapeutics (FRA:PHPN) Forward Dividend Yield %: 0.00% (As of Jul. 06, 2026)


FRA:PHPN Galectin Therapeutics Inc FRA:PHPN
22 GF Score
Price €3.76
! 5 Warning Signs
View Full Analysis

What is Galectin Therapeutics Forward Dividend Yield %?

Galectin Therapeutics FRA:PHPN 22 Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus rates FRA:PHPN with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 147 Biotechnology companies, Galectin Therapeutics ranks worse than 680271.43% on this metric.

As of today (2026-07-06), the Forward Annual Dividend Yield of Galectin Therapeutics is 0.00%.

As of today (2026-07-06), the Trailing Annual Dividend Yield of Galectin Therapeutics is 0.00%.

FRA:PHPN's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.26
* Ranked among companies with meaningful Forward Dividend Yield % only.

Galectin Therapeutics's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Galectin Therapeutics  (FRA:PHPN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Galectin Therapeutics Forward Dividend Yield % Related Terms

FRA:PHPN vs PALI, IRD, VSTM: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Galectin Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galectin Therapeutics Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galectin Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Galectin Therapeutics's Forward Dividend Yield % falls into.


FRA:PHPN
22GF Score
Galectin Therapeutics Inc FRA:PHPN
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galectin Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Galectin Therapeutics (FRA:PHPN) has a Forward Dividend Yield % of 0.00% as of Jul. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Galectin Therapeutics and its competitors. According to the industry distribution chart, Galectin Therapeutics ranks #999999 out of 147 companies in the Biotechnology industry.
Is Galectin Therapeutics' Forward Dividend Yield % too high?
Galectin Therapeutics' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Galectin Therapeutics ranks #999999 out of 147 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Galectin Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Galectin Therapeutics' Forward Dividend Yield % compare to PALI and IRD?
According to the Biotechnology industry distribution chart, Galectin Therapeutics ranks #999999 out of 147 companies for Forward Dividend Yield %. This places Galectin Therapeutics in the lower half of its industry. The industry median Forward Dividend Yield % is 1.26. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.26, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Galectin Therapeutics and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galectin Therapeutics's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galectin Therapeutics stock overvalued right now?
Galectin Therapeutics (FRA:PHPN) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Galectin Therapeutics' overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Galectin Therapeutics (FRA:PHPN), the current Forward Dividend Yield % is 0.00% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galectin Therapeutics Business Description

Other Exchanges GALT:USAPHPN:Germany
Address 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
22GF Score

Get the complete analysis for FRA:PHPN

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.76
Price